Thomas Richard Niethammer1, Martin Holzgruber2, Mehmet Fatih Gülecyüz2, Patrick Weber2, Matthias Frank Pietschmann2, Peter Ernst Müller2. 1. Department of Orthopaedic Surgery, Physical Medicine and Rehabilitation, University Hospital of Munich (LMU), Campus Grosshadern, Marchioninistr. 15, 81377, Munich, Germany. thomas.niethammer@med.uni-muenchen.de. 2. Department of Orthopaedic Surgery, Physical Medicine and Rehabilitation, University Hospital of Munich (LMU), Campus Grosshadern, Marchioninistr. 15, 81377, Munich, Germany.
Abstract
PURPOSE: The aim of this study is the investigation of the clinical results after third generation autologous chondrocyte implantation in the knee in a follow-up over three years post-operation. Our primary focus is on the effects of this procedure on children and adolescent patients as there is a lack of knowledge regarding the clinical outcomes in children/adolescents in particular when compared with adults. METHODS: A total of 40 patients (43 defects) <20 years with cartilage defects of the knee were treated with third generation ACI (Novocart® 3D). These defects were caused by osteochondritis dissecans (n = 13), acute trauma (<12 months) (n = 9), old trauma (>12 months) (n = 5) or unknown pathology (n = 13). The mean defect size was 5.2 cm2. IKDC subjective score and VAS (at rest and during activity) were used for clinical evaluation after 6, 12, 24 and 36 months post-operatively. The results of these patients were compared with 40 matched adult patients. Match paired analysis was performed by numbers of treated defects, defect location and defect size. All cartilage defects were arthroscopically classified with IKDC grade III-IV. All adult patients in the control group were treated with matrix based autologous chondrocyte implantation. RESULTS: All patients showed significantly better clinical results compared with the pre-operative findings in the follow-up over three years. We observed significantly better results in the IKDC score and VAS during the whole postoperative follow-up in children and adolescents after six, 12, 24 and 36 months compared with the adult control group. The IKDC score improved from 46.5 preoperative to 77.5 (+31) after three years in children and adolescents. Similarly, significantly lower stress pain after six months and one, two and three years was found in this group. CONCLUSION: This study showed that third generation autologous chondrocyte implantation is a suitable method for the treatment of full cartilage defects in children and adolescents.
PURPOSE: The aim of this study is the investigation of the clinical results after third generation autologous chondrocyte implantation in the knee in a follow-up over three years post-operation. Our primary focus is on the effects of this procedure on children and adolescent patients as there is a lack of knowledge regarding the clinical outcomes in children/adolescents in particular when compared with adults. METHODS: A total of 40 patients (43 defects) <20 years with cartilage defects of the knee were treated with third generation ACI (Novocart® 3D). These defects were caused by osteochondritis dissecans (n = 13), acute trauma (<12 months) (n = 9), old trauma (>12 months) (n = 5) or unknown pathology (n = 13). The mean defect size was 5.2 cm2. IKDC subjective score and VAS (at rest and during activity) were used for clinical evaluation after 6, 12, 24 and 36 months post-operatively. The results of these patients were compared with 40 matched adult patients. Match paired analysis was performed by numbers of treated defects, defect location and defect size. All cartilage defects were arthroscopically classified with IKDC grade III-IV. All adult patients in the control group were treated with matrix based autologous chondrocyte implantation. RESULTS: All patients showed significantly better clinical results compared with the pre-operative findings in the follow-up over three years. We observed significantly better results in the IKDC score and VAS during the whole postoperative follow-up in children and adolescents after six, 12, 24 and 36 months compared with the adult control group. The IKDC score improved from 46.5 preoperative to 77.5 (+31) after three years in children and adolescents. Similarly, significantly lower stress pain after six months and one, two and three years was found in this group. CONCLUSION: This study showed that third generation autologous chondrocyte implantation is a suitable method for the treatment of full cartilage defects in children and adolescents.
Authors: Jan M Pestka; Gerrit Bode; Gian Salzmann; Mathias Steinwachs; Hagen Schmal; Norbert P Südkamp; Philipp Niemeyer Journal: Am J Sports Med Date: 2013-10-28 Impact factor: 6.202
Authors: Brian J Cole; Thomas DeBerardino; Robert Brewster; Jack Farr; David W Levine; Carl Nissen; Prudence Roaf; Kenneth Zaslav Journal: Am J Sports Med Date: 2012-07-19 Impact factor: 6.202
Authors: Thomas R Niethammer; Thomas Niethammer; Siegfried Valentin; Andreas Ficklscherer; Mehmet F Gülecyüz; Mehmet Gülecyüz; Matthias F Pietschmann; Matthias Pietschmann; Peter E Müller; Peter Müller Journal: Int Orthop Date: 2015-05-07 Impact factor: 3.075
Authors: Philipp Niemeyer; Jan M Pestka; Gian M Salzmann; Norbert P Südkamp; Hagen Schmal Journal: Am J Sports Med Date: 2011-12-14 Impact factor: 6.202
Authors: P Niemeyer; S Andereya; P Angele; A Ateschrang; M Aurich; M Baumann; P Behrens; U Bosch; C Erggelet; S Fickert; J Fritz; H Gebhard; K Gelse; D Günther; A Hoburg; P Kasten; T Kolombe; H Madry; S Marlovits; N M Meenen; P E Müller; U Nöth; J P Petersen; M Pietschmann; W Richter; B Rolauffs; K Rhunau; B Schewe; A Steinert; M R Steinwachs; G H Welsch; W Zinser; D Albrecht Journal: Z Orthop Unfall Date: 2013-02-19 Impact factor: 0.923
Authors: Peter C Kreuz; Sebastian Müller; Arvind von Keudell; Thomas Tischer; Christian Kaps; Philipp Niemeyer; Christoph Erggelet Journal: Am J Sports Med Date: 2013-05-31 Impact factor: 6.202
Authors: Philipp Niemeyer; Gian Salzmann; Matthias Feucht; Jan Pestka; Stella Porichis; Peter Ogon; Norbert Südkamp; Hagen Schmal Journal: Int Orthop Date: 2014-05-17 Impact factor: 3.075
Authors: Ryan P Coughlin; Arnav Gupta; Olawale A Sogbein; Ajaykumar Shanmugaraj; Adrian Z Kurz; Nicole Simunovic; Yi-Meng Yen; Olufemi R Ayeni Journal: Curr Rev Musculoskelet Med Date: 2019-12
Authors: Juan Manuel Lopez-Alcorocho; Lucia Aboli; Isabel Guillen-Vicente; Elena Rodriguez-Iñigo; Marta Guillen-Vicente; Tomás F Fernández-Jaén; Santiago Arauz; Steve Abelow; Pedro Guillen-García Journal: Cartilage Date: 2017-02-15 Impact factor: 4.634
Authors: Alfred Hochrein; Wolfgang Zinser; Gunter Spahn; Peter Angele; Ingo Löer; Dirk Albrecht; Philipp Niemeyer Journal: Int Orthop Date: 2018-08-30 Impact factor: 3.075
Authors: Rosa S Valtanen; Armin Arshi; Benjamin V Kelley; Peter D Fabricant; Kristofer J Jones Journal: Cartilage Date: 2018-07-02 Impact factor: 4.634
Authors: Joshua S Everhart; Sravya Vajapey; James C Kirven; Moneer M Abouljoud; Alex C DiBartola; Brennan Wright; David C Flanigan Journal: Cartilage Date: 2019-05-14 Impact factor: 4.634
Authors: Ibrahim Fatih Cengiz; Hélder Pereira; Laura de Girolamo; Magali Cucchiarini; João Espregueira-Mendes; Rui L Reis; Joaquim Miguel Oliveira Journal: J Exp Orthop Date: 2018-05-22